financetom
Business
financetom
/
Business
/
Yum! Brands Q1 Adjusted Earnings Rise While Revenue Falls -- Shares Decline Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Yum! Brands Q1 Adjusted Earnings Rise While Revenue Falls -- Shares Decline Pre-Bell
May 1, 2024 5:29 AM

08:02 AM EDT, 05/01/2024 (MT Newswires) -- Yum! Brands ( YUM ) reported Q1 adjusted earnings Wednesday of $1.15 per diluted share, up from $1.06 a year earlier.

Analysts polled by Capital IQ expected $1.20.

Revenue for the quarter ended March 31 was $1.60 billion, down from $1.65 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.71 billion.

Shares of the company were down more than 5% in recent Wednesday premarket activity.

Price: 134.00, Change: -7.25, Percent Change: -5.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Newmark Group Opens Paris Office
Newmark Group Opens Paris Office
Mar 11, 2024
04:48 AM EDT, 03/11/2024 (MT Newswires) -- Newmark Group ( NMRK ) said Monday it has opened a Paris office and hired two French real estate industry veterans to oversee it in an attempt to increase its global revenues. The office, which has already opened, is led by chief business officer Francois Blin and deputy chief business officer Emmanuel Frenot....
Mesoblast Says FDA Supports Accelerated Approval Pathway for Heart Failure Treatment
Mesoblast Says FDA Supports Accelerated Approval Pathway for Heart Failure Treatment
Mar 11, 2024
05:13 AM EDT, 03/11/2024 (MT Newswires) -- Mesoblast (MESO) said Sunday the US Food and Drug Administration supports an accelerated approval for its rexlemestrocel-L cell therapy in end-stage heart failure patients with a left ventricular assist device. The regulator provided the feedback to the company in a February meeting. The product is being designed for patients with ischemic heart failure...
PHAXIAM Therapeutics Completes Delisting of ADS From Nasdaq
PHAXIAM Therapeutics Completes Delisting of ADS From Nasdaq
Mar 11, 2024
05:02 AM EDT, 03/11/2024 (MT Newswires) -- PHAXIAM Therapeutics ( PHXM ) said Monday the planned delisting of its American depositary shares from the Nasdaq Capital Market has taken effect. The company said it will also deregister its ADSs under the Securities Exchange Act of 1934 to suspend its reporting obligations. ...
Biden's meager 1% US defense budget increase buys fewer ships, jets
Biden's meager 1% US defense budget increase buys fewer ships, jets
Mar 11, 2024
WASHINGTON, March 11 (Reuters) - President Joe Biden's overall U.S. defense and national security budget request expected on Monday will be just 1% higher than last year, forcing a slowdown in spending on a wide range of programs and delaying efforts to rebuild weapons stocks depleted by wars in Ukraine and Israel. The $895 billion national security budget request, which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved